Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dentin collagen matrix is the principal organic scaffold of dentin, the hard tissue beneath tooth enamel and cementum. It consists mainly of type I collagen fibrils, which comprise about 90% of the organic matrix, with minor components of type III and type V collagen, and a variety of specialized non-collagenous proteins, proteoglycans, and acidic glycoproteins[1][4][5]. This matrix provides mechanical strength, elasticity, and resilience to dentin by forming a highly organized, triple-helical network of collagen fibers[1][5]. The non-collagenous proteins, including phosphoproteins (e.g., dentin matrix protein 1, osteopontin, decorin, and others), mediate nucleation, growth, and orientation of hydroxyapatite crystals, thus orchestrating the mineralization process that gives dentin its hardness[2][3][6]. The matrix is produced by odontoblasts and forms a three-dimensional scaffold traversed by tubules containing cell processes and facilitating signaling between the tooth surface and pulp[1][4]. The collagen matrix is also subject to enzymatic degradation by host enzymes (e.g., matrix metalloproteinases) during dental diseases such as caries[4][8]. Additional notes on correctness and target status: - The term "Dentin collagen matrix" does not refer to a specific therapeutic target such as a receptor, enzyme, or transporter, but to a structural protein network in dentin[1][4][5]. - It is not considered a therapeutic target in drug discovery; however, the degradation of this matrix is relevant to dental disease pathology, and interventions (e.g., MMP inhibitors) may be developed to preserve matrix integrity[8]. - Individual dentin matrix proteins (e.g., dentin matrix acidic phosphoprotein 1 or DMP1, dentin sialophosphoprotein or DSPP) can be considered protein targets, but the entire collagen matrix is not a single molecular target. In summary, "Dentin collagen matrix" is a fibrous protein scaffold essential for tooth structure and function, but it is not a druggable molecular target or receptor in the classical sense[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin collagen matrix.